Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants
- Status
- TERMINATED
- Phase
- PHASE2
Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE2
NK Cells in Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2
- Status
- COMPLETED
- Phase
- PHASE2
Randomised Trial in Waldenstrom's Macroglobulinaemia
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2